AlphaFold predicted structure
ACP5 · P13686

Mean pLDDT
94.6/ 100
Very high
325 residues
Confidence breakdown
- Very high(≥ 90)92%
- Confident(70–90)2%
- Low(50–70)0%
- Very low(< 50)6%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
acid phosphatase 5, tartrate resistant
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
COVID-19 research
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntracerebral calcification disorders
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalWhite matter disorders and cerebral calcification - narrow panel
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomal+1 more panels — install the extension to see the full list inline on any page.
Spondyloenchondrodysplasia with immune dysregulation
hereditary disease
type 1 interferonopathy
Alzheimer disease
Parkinson disease
lysosomal storage disease
neurodegenerative disease
multiple sclerosis
thrombophilia
Abnormality of the skeletal system
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Tartrate-resistant acid phosphatase type 5
Involved in osteopontin/bone sialoprotein dephosphorylation. Its expression seems to increase in certain pathological states such as Gaucher and Hodgkin diseases, the hairy cell, the B-cell, and the T-cell leukemias
ACP5 · P13686

Mean pLDDT
94.6/ 100
Very high
325 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0